Lineage Cell Therapeutics (LCTX) Prepaid Assets (2010 - 2026)

Lineage Cell Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• On a quarterly basis, Prepaid Assets rose 5.95% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 5.95% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, down 2.7% from the prior year.
• Prepaid Assets retreated to $2.0 million in Q1 2026 per LCTX's latest filing, from $2.5 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $2.6 million in Q1 2023 and bottomed at $1.3 million in Q3 2024.
• The 5-year median for Prepaid Assets is $1.8 million (2022), against an average of $1.9 million.
• Across the five-year window, Prepaid Assets tumbled 48.54% in 2022 and soared 86.69% in 2023, its largest moves.
• Year by year, Prepaid Assets stood at $1.8 million in 2022, then climbed by 20.57% to $2.2 million in 2023, then advanced by 15.88% to $2.6 million in 2024, then decreased by 2.7% to $2.5 million in 2025, then dropped by 20.44% to $2.0 million in 2026.
• Per Business Quant, the three latest LCTX Prepaid Assets figures stand at $2.0 million (Q1 2026), $2.5 million (Q4 2025), and $1.6 million (Q3 2025).